This review seeks to familiarize the readers with RSV rapid antigen-detection tests, describe their performance characteristics and comment on their strengths and weaknesses. The authors will ...

This evanescent but critical antigen-binding site made RSV vaccine development difficult. However, mRNA technology allows “more hypothesis-driven complex vaccine design”, says Carfi ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

Just like adults under 60, elderly adults who get RSV tend to have mild symptoms, such as runny nose, sore throat, cough, ...

Vaxxas, has announced the company has been granted a licence to develop a next-generation vaccine antigen (DS2).

Licensed to Vaxxas for worldwide use, this next-generation vaccine antigen (DS2) was developed and optimized by NIH’s scientists to prompt a more robust and durable immune response against RSV ...

The immune system remembers how to protect the body against this antigen in the future. If the body encounters RSV later, the immune system will be able to quickly recognize the virus and disable ...

Respiratory syncytial virus cases are rising all over the country ... In Florida, 24.3% of antigen tests and 23.9% of PCR tests taken the week of Nov. 11 were positive—a seismic increase from ...

Pediatric RSV off-season outbreaks and positivity rates increased in China during the COVID-19 pandemic, according to study findings.

Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology ...

The second group of viral antigen-based techniques consists of commercially available immunoassays, commonly referred to as RADTs. Compared with IF, the principle of RSV RADTs is similar in that a ...